|
Volumn 147, Issue 10, 2007, Pages 677-684
|
Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
INTERFERON;
PEGINTERFERON;
RIBAVIRIN;
VIRUS RNA;
ALPHA2B INTERFERON;
ANTIVIRUS AGENT;
ADULT;
ARTICLE;
CANADA;
CHRONIC HEPATITIS;
COHORT ANALYSIS;
DEATH;
EUROPE;
FEMALE;
FOLLOW UP;
HEPATITIS C;
HUMAN;
KAPLAN MEIER METHOD;
LIVER BIOPSY;
LIVER CARCINOMA;
LIVER CIRRHOSIS;
LIVER FAILURE;
LIVER FIBROSIS;
LIVER TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MALE;
MONOTHERAPY;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
RECURRENCE RISK;
RETROSPECTIVE STUDY;
STATISTICAL ANALYSIS;
BLOOD;
CLINICAL TRIAL;
DRUG COMBINATION;
LIVER CELL CARCINOMA;
LIVER TUMOR;
MIDDLE AGED;
MORTALITY;
MULTICENTER STUDY;
TREATMENT OUTCOME;
VIROLOGY;
ADULT;
ANTIVIRAL AGENTS;
CARCINOMA, HEPATOCELLULAR;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
HEPATITIS C, CHRONIC;
HUMANS;
INTERFERON ALFA-2B;
LIVER CIRRHOSIS;
LIVER FAILURE;
LIVER NEOPLASMS;
LIVER TRANSPLANTATION;
MALE;
MIDDLE AGED;
RETROSPECTIVE STUDIES;
RIBAVIRIN;
RNA, VIRAL;
TREATMENT OUTCOME;
|
EID: 38449091418
PISSN: 00034819
EISSN: None
Source Type: Journal
DOI: 10.7326/0003-4819-147-10-200711200-00003 Document Type: Article |
Times cited : (541)
|
References (28)
|